Bio-Key International Inc (BKYI) Shares Up Despite Recent Market Volatility

Bio-Key International Inc (NASDAQ: BKYI)’s stock price has increased by 113.83 compared to its previous closing price of 1.37. However, the company has seen a 73.34% increase in its stock price over the last five trading sessions. accesswire.com reported 2025-01-10 that ATLANTIC CITY, NJ and HOLMDEL, NJ / ACCESSWIRE / January 10, 2025 / BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless, and phish-resistant authentication, will present and meet with investors at DealFlow Event’s Microcap Conference on Wednesday, January 29th & 30th at the Borgata hotel in Atlantic City, New Jersey. CEO Mike DePasquale will present at 2:00pm ET on Wednesday and be available for meetings both days.

Is It Worth Investing in Bio-Key International Inc (NASDAQ: BKYI) Right Now?

Additionally, the 36-month beta value for BKYI is 0.02. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

The public float for BKYI is 2.33M and currently, short sellers hold a 12.89% ratio of that float. The average trading volume of BKYI on January 15, 2025 was 2.39M shares.

BKYI’s Market Performance

BKYI stock saw an increase of 73.34% in the past week, with a monthly gain of 192.95% and a quarterly increase of 350.00%. The volatility ratio for the week is 20.16%, and the volatility levels for the last 30 days are 21.04% for Bio-Key International Inc (BKYI). The simple moving average for the last 20 days is 108.16% for BKYI stock, with a simple moving average of 110.50% for the last 200 days.

Analysts’ Opinion of BKYI

Many brokerage firms have already submitted their reports for BKYI stocks, with Maxim Group repeating the rating for BKYI by listing it as a “Buy.” The predicted price for BKYI in the upcoming period, according to Maxim Group is $6 based on the research report published on March 26, 2021 of the previous year 2021.

BKYI Trading at 147.20% from the 50-Day Moving Average

After a stumble in the market that brought BKYI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.02% of loss for the given period.

Volatility was left at 21.04%, however, over the last 30 days, the volatility rate increased by 20.16%, as shares surge +181.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +105.96% upper at present.

During the last 5 trading sessions, BKYI rose by +60.87%, which changed the moving average for the period of 200-days by +29.46% in comparison to the 20-day moving average, which settled at $1.3968. In addition, Bio-Key International Inc saw 71.32% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for BKYI

Current profitability levels for the company are sitting at:

  • -1.45 for the present operating margin
  • 0.15 for the gross margin

The net margin for Bio-Key International Inc stands at -1.42. The total capital return value is set at -17.5. Equity return is now at value -527.28, with -112.56 for asset returns.

Based on Bio-Key International Inc (BKYI), the company’s capital structure generated 0.95 points at debt to capital in total, while cash flow to debt ratio is standing at -1.6. The debt to equity ratio resting at 18.52. The interest coverage ratio of the stock is -53.97.

Currently, EBITDA for the company is -7.85 million with net debt to EBITDA at -0.08. When we switch over and look at the enterprise to sales, we see a ratio of 1.5. The receivables turnover for the company is 3.23for trailing twelve months and the total asset turnover is 1.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.78.

Conclusion

In conclusion, Bio-Key International Inc (BKYI) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts